Brilinta® is used to lower your risk of having a stroke or serious heart problems after you have had a heart attack or severe chest pain (angina) by prewenting blood clots forming.

Cialis® is in a class of drugs called Phosphodiesterase Enzyme Inhibitors. It is used to treat erection problems in men. Cialis® is manufactured by Eli Lilly.

Farxiga® (Dapagliflozin) is an oral diabetes medicine that helps control blood sugar levels. Farxiga® works by helping the kidneys get rid of glucose from your bloodstream. Farxiga® is used together with diet and exercise improve blood sugar control in adults with type 2 diabetes mellitus. Farxiga® is not for treating type 1 diabetes.

Kombiglyze XR® contains a combination of metformin and saxagliptin. Metformin and saxagliptin are oral diabetes medicines that help control blood sugar levels. Metformin works by decreasing glucose (sugar) production in the liver and decreasing absorption of glucose by the intestines. Saxagliptin works by regulating the levels of insulin your body produces after eating. Kombiglyze XR® is used together with diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus.

Levitra® is a medciation for the treatment of male Impotence manufactured by Bayer Pharmaceuticals Corp. It helps to archieve and maintain erection.

Restasis® - ophthalmic emulsion containing 0.05% of cyclosporine, made by Allergan, which is indicated to increase tear production in patients whose tear production is presumed to be suppressed due to ocular inflammation associated with keratoconjunctivitis sicca. Increased tear production was not seen in patients currently taking topical anti-inflammatory drugs or using punctal plugs.

Viagra® is a brand of Sildenafil Citrate used for treating male impotence (Erectile Dysfunction). It is manufactured by Pfizer.

Xalacom® - an antiglaucoma combined drug with a miotic effect. Each ml of Xalacom® contains Latanoprost 50mcg and Timolol Maleate LP equivalent to timolol 5mg. These substances contribute to the effective reduction of increased intraocular pressure, due to two different mechanisms of action, which contributes to a better clinical effect in comparison with monotherapy.